The relationship between akathisia and subjective tolerability in patients with schizophrenia

International Journal of Neuroscience

Volumn 120, Issue 7, 2010, Pages 507-511

  Kim, Jong Hoon ^a   Byun, Hee Jung ^b  

^a Gachon University   (South Korea)

^b Seoul Children's Hospital   (South Korea)

Author keywords

Akathisia; Antipsychotics; Extrapyramidal side effect; Schizophrenia; Subjective tolerability

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; RISPERIDONE;

ADULT; AGITATION; AKATHISIA; ANALYSIS OF COVARIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; OUTPATIENT; RATING SCALE; SCHIZOPHRENIA; SIDE EFFECT;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; AUTONOMIC NERVOUS SYSTEM DISEASES; BASAL GANGLIA DISEASES; DRUG TOLERANCE; FEMALE; HUMANS; MALE; RISK ASSESSMENT; RISPERIDONE; SCHIZOPHRENIA;

EID: 77954184223     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207451003760106     Document Type: Article

References (26)

1. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press.
2. Barbui, C., Nos̀e, M., Bindman, J., Schene, A., Becker, T., Mazzi,M. A., et al. (2005). Sex differences in the subjective tolerability of antipsychotic drugs. Journal of Clinical Psychopharmacology, 25, 521-526.
3. Barnes, T. R. (1989). A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154, 672-676.
4. Barnes, T. R. E. (1994). Antipsychotic Drugs and Their Side-Effects. London: Academic Press.
5. Cem Atbaşoglu, E., Schultz, S. K., & Andreasen, N. C. (2001). The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 13, 336-341.
6. Cheshire, W. P., Jr. (2000). Hypotensive akathisia: autonomic failure associated with leg fidgeting while sitting. Neurology, 55, 1923-1926.
7. Chong, S. A., Mythily, S., & Remington, G. (2003). Clinical characteristics and associated factors in antipsychotic-induced akathisia of Asian patients with schizophrenia. Schizophrenia Research, 59, 67-71.
8. Day, J. C., Wood, G., Dewey, M., & Bentall, R. P. (1995). A selfrating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. British Journal of Psychiatry, 166, 650-653.
9. Hansen, L. K. (2008). Akathisia-seen from the patients' perspective. Journal of Psychopharmacology, 22, 572-573.
10. Hansen, L., & Kingdom, D. (2006). Akathisia as a risk factor for suicide. British Journal of Psychiatry, 188, 192.
11. Hirose, S. (2003). The causes of underdiagnosing akathisia. Schizophrenia Bulletin, 29, 547-558.
12. Iqbal, N., Lambert, T., & Masand, P. (2007). Akathisia: problem of history or concern of today. CNS Spectrums, 12(9 Suppl. 14), 1-13.
13. Kane, J. M., Fleischhacker, W. W., Hansen, L., Perlis, R., Pikalov, A., 3rd., & Assunção-Talbott, S. (2009). Akathisia: An updated review focusing on second-generation antipsychotics. Journal of Clinical Psychiatry, 70, 627-643.
14. Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
15. Kim, J. H., Jung, H. Y., Kang, U. G., Jeong, S. H., Ahn, Y. M., Byun, H. J., et al. (2002).Metric characteristics of theDIEPSS: A practical combined rating scale for drug-induced movement disorders. Movement Disorders, 17, 1354-1359.
16. Kim, J. H., Jin, Y. H., Kang, U. G., Ahn, Y. M., Ha, K. S., & Kim, Y. S. (2005). Neuroleptic-induced acute and chronic akathisia: a clinical comparison. Movement Disorders, 20, 1667-1670.
17. Kim, J. H., & Kim, M. J. (2009). Association of adverse drug effects with subjective well-being in patients with schizophrenia receiving stable doses of risperidone. Clinical Neuropharmacology, 32, 250-253.
18. Kumar, R., & Sachdev, P. S. (2009). Akathisia and second-generation antipsychotic drugs. Current Opinion Psychiatry, 22, 293-299.
19. Lambert, T. J., Cock, N., Alcock, S. J., Kelly, D. L., & Conley, R. R. (2003). Measurement of antipsychotic-induced side effects: Support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement. Human Psychopharmacology, 18, 405-411.
20. Marder, S. R. (2005). Subjective experiences on antipsychotic medications: Synthesis and conclusions. Acta Psychiatrica Scandinavica Supplementum, 427, 43-46.
21. Nair, C. J., Josiassen, R. C., Abraham,G., Stanilla, J. K., Tracy, J. I., & Simpson, G. M. (1999). Does akathisia influence psychopathology in psychotic patients treated with clozapine? Biological Psychiatry, 45, 1376-1383.
22. Owens, D. G. C. (1999). A Guide to the Extrapyramidal Side-Effects of antipsychotic Drugs. Cambridge: Cambridge University Press.
23. Rosebush, P. I., & Mazurek, M. F. (1999). Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone. Neurology, 52, 782-785.
24. Sachdev, P. (1995). Akathisia and Restless Legs. New York: Cambridge University Press.
25. Van Putten, T., & Marder, S. R. (1987). Behavioral toxicity of antipsychotic drugs. Journal of Clinical Psychiatry, 48, 13-19.
26. Voruganti, L. N., & Awad, A. G. (2006). Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia-Findings from an in vivo SPECT study. Schizophrenia Research, 88, 179-186.